iBio Inc.

4.09
0.18 (4.60%)
At close: Apr 02, 2025, 3:59 PM
3.97
-3.05%
After-hours: Apr 02, 2025, 07:55 PM EDT

iBio Statistics

Share Statistics

iBio has 9.87M shares outstanding. The number of shares has increased by 14.51% in one year.

Shares Outstanding 9.87M
Shares Change (YoY) 14.51%
Shares Change (QoQ) 7.93%
Owned by Institutions (%) 0.08%
Shares Floating 8.6M
Failed to Deliver (FTD) Shares 9.8K
FTD / Avg. Volume 1.92%

Short Selling Information

The latest short interest is 242K, so 2.64% of the outstanding shares have been sold short.

Short Interest 242K
Short % of Shares Out 2.64%
Short % of Float 2.72%
Short Ratio (days to cover) 1.91

Valuation Ratios

The PE ratio is -0.31 and the forward PE ratio is -1.43. iBio's PEG ratio is 0.

PE Ratio -0.31
Forward PE -1.43
PS Ratio 34.22
Forward PS 356.4
PB Ratio 0.36
P/FCF Ratio -0.41
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for iBio.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.21.

Current Ratio 4.08
Quick Ratio 4.08
Debt / Equity 0.21
Debt / EBITDA -0.32
Debt / FCF -0.24
Interest Coverage -96.71

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $14.06K
Profits Per Employee $-1.56M
Employee Count 16
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 36.01% in the last 52 weeks. The beta is 1.3, so iBio's price volatility has been higher than the market average.

Beta 1.3
52-Week Price Change 36.01%
50-Day Moving Average 4.16
200-Day Moving Average 2.76
Relative Strength Index (RSI) 39.09
Average Volume (20 Days) 510.56K

Income Statement

In the last 12 months, iBio had revenue of 225K and earned -24.91M in profits. Earnings per share was -6.5.

Revenue 225K
Gross Profit 225K
Operating Income -16.63M
Net Income -24.91M
EBITDA -14.02M
EBIT -15.27M
Earnings Per Share (EPS) -6.5
Full Income Statement

Balance Sheet

The company has 14.21M in cash and 4.46M in debt, giving a net cash position of 9.75M.

Cash & Cash Equivalents 14.21M
Total Debt 4.46M
Net Cash 9.75M
Retained Earnings -313.85M
Total Assets 21.7M
Working Capital 3.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.55M and capital expenditures -210K, giving a free cash flow of -18.76M.

Operating Cash Flow -18.55M
Capital Expenditures -210K
Free Cash Flow -18.76M
FCF Per Share -4.9
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -7392.89% and -11069.78%.

Gross Margin 100%
Operating Margin -7392.89%
Pretax Margin -6863.56%
Profit Margin -11069.78%
EBITDA Margin -6231.56%
EBIT Margin -7392.89%
FCF Margin -8339.56%

Dividends & Yields

IBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for IBIO is $5, which is 28.5% higher than the current price. The consensus rating is "Buy".

Price Target $5
Price Target Difference 28.5%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:20.

Last Split Date Nov 29, 2023
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -19.74
Piotroski F-Score 4